Weigao Medical Polymer wins CSRC filing for 48.3 million unlisted-to-H share conversion

Reuters04-01
Weigao Medical Polymer wins CSRC filing for 48.3 million unlisted-to-H share conversion
  • Shandong Weigao Group Medical Polymer received China Securities Regulatory Commission filing notice for conversion of 48.3 million unlisted shares into H shares.
  • Converted shares represent 1.06% of issued share capital.
  • H shares will list on Hong Kong Stock Exchange main board once listing approval is granted.
  • CSRC filing notice remains valid for 12 months from March 26, 2026.
  • Issued share capital totals 4,570.6 million shares, including 4,522.3 million H shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Weigao Group Medical Polymer Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260401-12092863), on April 01, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment